Category:
Chiral Intermediates
CAS NO:
183319-69-9
Standard:
In-house Standards,
Erlotinib hydrochloride is a small molecule epidermal growth factor receptor tyrosine kinase reversible inhibitor, mainly used for the second or third line treatment of locally advanced or metastatic non-small cell lung cancer and pancreatic cancer.